Anja Vogelmann

PhD Student

University of Freiburg
Institute of Pharmaceutical Sciences

2022 PhD thesis, Albert-Ludwigs-University of Freiburg
2019 - 2022 PhD student in the lab of Prof. Dr. Manfred Jung, Institute of Pharmaceutical Sciences (Medicinal Chemistry), University of Freiburg
2018 - 2019 Diploma grade in pharmacy (Dipl. Pharm.), University of Freiburg
with research stay at the University of Copenhagen
2018 3rd State-accredited Examination (3. Staatsexamen) and Pharmaceutical License (Approbation)
2017 - 2018 Pharmacist in practical training, Bad Krozingen and Ulm
2017 2nd State-accredited Examination (2. Staatsexamen), Freiburg
2014 1st State-accredited Examination (1. Staatsexamen), Freiburg
2012 - 2017 Studies of Pharmaceutical Sciences at the University of Freiburg

Awards, scholarships

2013 Scholarship “Deutschlandstipendium”


  • Vogelmann A., Schiedel M., Wössner N., Merz A., Herp D., Hammelmann S., Colcerasa A., Komaniecki G., Hong J.Y., Sum M., Metzger E., Neuwirt E., Zhang L., Einsle O., Groß O., Schüle R., Lin H., Sippl W. and Jung M. (2022) Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration. RSC Chemical Biology doi: 10.1039/D1031CB00244A.
  • Vogelmann A., Jung M., Hansen F.K. and Schiedel M. (2022) Comparison of Cellular Target Engagement Methods for the Tubulin Deacetylases Sirt2 and HDAC6: NanoBRET, CETSA, Tubulin Acetylation, and PROTACs. ACS Pharmacol Transl Sci 5, 138-140.
  • Vogelmann A., Robaa D., Sippl W. and Jung M. (2020) Proteolysis targeting chimeras (PROTACs) for epigenetics research. Curr Opin Chem Biol 57, 8-16.
  • Brosowsky J., Lutterbeck M., Liebich A., Keller M., Herp D., Vogelmann A., Jung M. and Breit B. (2020) Syntheses of Thailandepsin B Pseudo-Natural Products: Access to New Highly Potent HDAC Inhibitors via Late-Stage Modification. Chemistry, doi: 10.1002/chem.202002449.